| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis C Saponaro, M Gaggini, F Carli, A Gastaldelli Nutrients 7 (11), 9453-9474, 2015 | 489 | 2015 |
| Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance M Gaggini, F Carli, C Rosso, E Buzzigoli, M Marietti, V Della Latta, ... Hepatology 67 (1), 145-158, 2018 | 370 | 2018 |
| NASH in lean individuals R Younes, E Bugianesi Seminars in liver disease 39 (01), 086-095, 2019 | 233 | 2019 |
| Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease C Rosso, K Kazankov, R Younes, S Esmaili, M Marietti, M Sacco, F Carli, ... Journal of hepatology 71 (5), 1012-1021, 2019 | 160 | 2019 |
| Brain leptin reduces liver lipids by increasing hepatic triglyceride secretion and lowering lipogenesis MT Hackl, C Fürnsinn, CM Schuh, M Krssak, F Carli, S Guerra, ... Nature communications 10 (1), 2717, 2019 | 93 | 2019 |
| Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes M Meroni, P Dongiovanni, M Longo, F Carli, G Baselli, R Rametta, ... EBioMedicine 52, 2020 | 80 | 2020 |
| PPAR‐γ‐induced changes in visceral fat and adiponectin levels are associated with improvement of steatohepatitis in patients with NASH A Gastaldelli, S Sabatini, F Carli, M Gaggini, F Bril, R Belfort‐DeAguiar, ... Liver International 41 (11), 2659-2670, 2021 | 62 | 2021 |
| TM6SF2/PNPLA3/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models M Longo, M Meroni, E Paolini, V Erconi, F Carli, F Fortunato, D Ronchi, ... Cellular and Molecular Gastroenterology and Hepatology 13 (3), 759-788, 2022 | 57 | 2022 |
| Pioglitazone even at low dosage improves NAFLD in type 2 diabetes: clinical and pathophysiological insights from a subgroup of the TOSCA. IT randomised trial G Della Pepa, M Russo, M Vitale, F Carli, C Vetrani, M Masulli, G Riccardi, ... Diabetes research and clinical practice 178, 108984, 2021 | 52 | 2021 |
| Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals C Saponaro, S Sabatini, M Gaggini, F Carli, C Rosso, V Positano, ... Liver International 42 (11), 2418-2427, 2022 | 37 | 2022 |
| Biomonitoring of Bis (2-ethylhexyl) phthalate (DEHP) in Italian children and adolescents: Data from LIFE PERSUADED project S Tait, F Carli, L Busani, E Buzzigoli, V Della Latta, A Deodati, E Fabbrizi, ... Environmental research 185, 109428, 2020 | 31 | 2020 |
| Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease M Gaggini, F Carli, C Rosso, R Younes, R D’Aurizio, E Bugianesi, ... International journal of molecular sciences 20 (24), 6333, 2019 | 30 | 2019 |
| Interplay between oxidative stress and metabolic derangements in non-alcoholic fatty liver disease: the role of selenoprotein P GP Caviglia, C Rosso, A Armandi, M Gaggini, F Carli, ML Abate, A Olivero, ... International Journal of Molecular Sciences 21 (22), 8838, 2020 | 23 | 2020 |
| The LIFE PERSUADED project approach on phthalates and bisphenol A biomonitoring in Italian mother-child pairs linking exposure and juvenile diseases C La Rocca, F Maranghi, S Tait, R Tassinari, F Baldi, G Bottaro, ... Environmental Science and Pollution Research 25, 25618-25625, 2018 | 19 | 2018 |
| Assessment of exposure to di-(2-ethylhexyl) phthalate (DEHP) metabolites and bisphenol A (BPA) and its importance for the prevention of cardiometabolic diseases F Carli, D Ciociaro, A Gastaldelli Metabolites 12 (2), 167, 2022 | 18 | 2022 |
| The subtle balance between lipolysis and lipogenesis: a critical point in metabolic homeostasis. Nutrients 7 9453–9474 C Saponaro, M Gaggini, F Carli, A Gastaldelli | 16 | 2015 |
| Mechanisms for increased risk of diabetes in chronic liver diseases G Svegliati‐Baroni, M Gaggini, F Carli, C Barbieri, M Cucco, R Younes, ... Liver International 40 (10), 2489-2499, 2020 | 15 | 2020 |
| Phthalates exposure as determinant of albuminuria in subjects with type 2 diabetes: a cross-sectional study A Mengozzi, F Carli, E Biancalana, V Della Latta, M Seghieri, ... The Journal of Clinical Endocrinology & Metabolism 104 (5), 1491-1499, 2019 | 15 | 2019 |
| The color of fat and its central role in the development and progression of metabolic diseases M Gaggini, F Carli, A Gastaldelli Hormone molecular biology and clinical investigation 31 (1), 20170060, 2017 | 14 | 2017 |
| Juvenile toxicity rodent model to study toxicological effects of Bisphenol A (BPA) at dose levels derived from Italian children biomonitoring study R Tassinari, L Narciso, S Tait, L Busani, A Martinelli, A Di Virgilio, F Carli, ... Toxicological Sciences 173 (2), 387-401, 2020 | 13 | 2020 |
